Fundz

Eyestem Research has raised $10 million in a Series B round.

PRIVATEAug 11, 2025

Amount Raised

$10 Million

Round Type

Series B

BengaluruBiotechnologyHealth CareTherapeutics

Investors

Raju Barwale

Description

Eyestem Research has successfully secured $10 million in its Series B funding round. This financing will help the company advance its research in innovative eye treatments. The funding round was led by prominent investors. Eyestem aims to enhance its product development with these new funds.

Quick answer

Eyestem raised $10 Million in a Series B round, dated August 11, 2025. Investors: Raju Barwale. Eyestem is based in Bengaluru, Karnataka, India.

How much did Eyestem raise?
Eyestem raised $10 Million in a Series B round on August 11, 2025.
Who invested in Eyestem?
Raju Barwale is named as investors in this round.
What does Eyestem do?
Eyestem Research focuses on developing cell replacement therapies for incurable eye diseases.
Where is Eyestem based and how big is it?
Eyestem is based in Bengaluru, Karnataka, India.
Who are the decision-makers at Eyestem?
Fundz holds 1 contact at Eyestem. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Eyestem that raised within 45 days of this round, from Fundz verified event records.

  • MAIA Biotechnology raised $2.3M (Grant) on September 24, 2025.
  • Santhera Pharmaceuticals raised $21M (Funding Round) on September 23, 2025.
  • AusperBio raised $63M (Series B) on September 22, 2025.
  • Nuclide Therapeutics raised $6.7M (Seed) on September 22, 2025.
  • Revive Therapeutics raised $91K (Post-IPO Equity) on September 19, 2025.
  • ARTHEx Biotech raised $87M (Series B) on September 17, 2025.

Who to call at Eyestem, and when

A new round usually means Eyestem is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eyestem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eyestem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eyestem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eyestem

Location

Bellary Road

Bengaluru, Karnataka, India

About

Eyestem Research focuses on developing cell replacement therapies for incurable eye diseases. The company is known for its work on dry age-related macular degeneration (AMD). It is developing a therapy called Eyecyte-RPE, which uses retinal pigment epithelium (RPE) cells derived from human induced pluripotent stem cells to replace damaged cells in the retina.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eyestem raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Eyestem's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Eyestem raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.